Your browser doesn't support javascript.
loading
CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
Shen, Mingfang; Zhang, Yunfeng; Tang, Lun; Fu, Qinyan; Zhang, Jiawei; Xu, Yang; Zeng, Hui; Li, Yuan.
  • Shen M; Department of Hematology, the First Hospital of Jiaxing, 314001, Zhejiang, China.
  • Zhang Y; Department of Hematology, the First Hospital of Jiaxing, 314001, Zhejiang, China.
  • Tang L; Department of Hematology, the First Hospital of Jiaxing, 314001, Zhejiang, China.
  • Fu Q; Department of Hematology, the First Hospital of Jiaxing, 314001, Zhejiang, China.
  • Zhang J; Department of Hematology, the Second Affiliated Hospital, Zhejiang University School of Medicine, 310009, Zhejiang, China.
  • Xu Y; Department of Hematology, the Second Affiliated Hospital, Zhejiang University School of Medicine, 310009, Zhejiang, China.
  • Zeng H; Department of Hematology, the First Hospital of Jiaxing, 314001, Zhejiang, China. zhwuhan@163.com.
  • Li Y; Department of Hematology, the First Hospital of Jiaxing, 314001, Zhejiang, China. anne_263@sina.com.
BMC Cancer ; 23(1): 978, 2023 Oct 13.
Article en En | MEDLINE | ID: mdl-37833632
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article